For The First Time In The Middle East, Abu Dhabi Stem Cells Center And Yas Clinic Khalifa City Are Awarded Comprehensive Fact Accreditation For The Abu Dhabi Bone Marrow Transplant

Abu Dhabi, 30, December 2025: Abu Dhabi Stem Cells Center (ADSCC) and Yas Clinic Khalifa City have been awarded internationally recognized accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) for the Abu Dhabi Bone Marrow Transplant (ADBMT) Program. This accreditation recognizes the program’s full compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing, and Administration, highlighting ADSCC and Yas Clinic Khalifa City as leaders in hematopoietic stem cell transplantation and cellular therapy in the region.

ADSCC and Yas Clinic Khalifa City have earned FACT Accreditation for a comprehensive range of programs and services inspected under the ADBMT Program. These include adult and pediatric allogeneic and autologous hematopoietic progenitor cell transplantation, immune effector cellular therapy, marrow cellular therapy product collection for administration and further manufacturing, cellular therapy product collection by apheresis for administration and further manufacturing, and cellular therapy product processing with minimal and more than minimal manipulation performed at the Abu Dhabi Stem Cells Center Processing and MTM (manufacturing of cellular therapy products) laboratory.

This achievement makes the ADBMT Program. under ADSCC, the only program in the Middle East to hold accreditation for all of these advanced cellular therapy services, reinforcing ADSCC’s position as designated Centre of Excellence for Hematopoietic Stem Cell Transplantation by the Department of Health - Abu Dhabi.

FACT is an internationally recognized accrediting body for hospitals and medical institutions offering stem cell transplantation and cellular therapy. Accreditation signifies that an institution meets the most rigorous global standards across every aspect of cellular therapy, including clinical care, donor management, cell collection, processing, storage, transportation, administration, and cell release.

ADSCC is widely recognized as a highly organized and fully integrated institution with exceptional efficiency across clinical, laboratory, and collection operations. The center maintains comprehensive documentation to support staff training, accreditation, and human resource management. Clinical programs are led by an elite team of specialists committed to delivering high-quality patient care. The center’s facilities, including the marrow collection unit, apheresis unit, and cellular therapy processing and MTM laboratory, are well-equipped, staffed with experienced personnel, and supported by dedicated leadership. Quality assurance systems and regulatory compliance measures further ensure the highest standards in both clinical and laboratory operations.

FACT-JACIE standards are developed by leading experts based on the latest scientific and clinical knowledge in cellular therapy and transplantation. ADSCC and Yas Clinic Khalifa City have once again demonstrated adherence to these demanding standards, reinforcing their commitment to delivering excellence and safety in advanced cellular therapies.

Achieving FACT accreditation represents the highest benchmark of quality and professionalism in cellular therapy worldwide, and underscores the dedication of the teams at Abu Dhabi Stem Cells Center and Yas Clinic Khalifa City to uphold the most rigorous international standards in transplantation and cellular therapy.

“As Executive Director of the Abu Dhabi Bone Marrow Transplant Program, I am honored to guide our teams in setting the benchmark for cellular therapy in the region,” said Dr. Fatima Al Kaabi. “This FACT accreditation reflects our strategic vision, operational excellence, and commitment to delivering world-class care for patients in Abu Dhabi and beyond.”

“Achieving FACT accreditation demonstrates the dedication of our teams at ADSCC to excellence in cellular product processing, research, and operational efficiency,” said Prof. Yendry Ventura, CEO of Abu Dhabi Stem Cells Center. “It is a testament to the center’s position as a regional leader in cellular therapies, cell preparation, and regenerative medicine.”

FACT conducted an extensive on-site evaluation of ADSCC and Yas Clinic Khalifa City, including a detailed review of documentation and inspection of facilities to assess compliance with FACT standards as well as U.S. FDA Good Tissue Practice regulations.